BRISTOL MYERS SQUIBB CO BMY
NYSE · XNYS · stock · Pharmaceutical Preparations
Chart by TradingView
7/9
Piotroski F — financial health
—
Altman Z″ — distress risk
71.5%
Dividend payout · stretched
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $48.2B | $7.1B | — | $12.8B | $18.5B |
| 2024 | $48.3B | -$8.9B | — | $13.9B | $16.3B |
| 2023 | $45.0B | $8.0B | — | $12.7B | $29.4B |
| 2022 | $46.2B | $6.3B | — | $11.9B | $31.1B |
| 2021 | $46.4B | $7.0B | — | $15.2B | $35.9B |
| 2020 | $42.5B | -$9.0B | $30.7B | $13.3B | $37.9B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Haller Julia A | director | 2026-06-15 | Option exercise | 20,460 | $53.76 |
| Short Bartie Wendy | EVP, Corporate Affairs | 2026-06-03 | Option exercise | 8,040 | — |
| Short Bartie Wendy | EVP, Corporate Affairs | 2026-06-03 | Tax withheld | 3,876 | $54.72 |
| Lenkowsky Adam | EVP, Chief Commercial Officer | 2026-05-01 | Option exercise | 1,373 | — |
| Lenkowsky Adam | EVP, Chief Commercial Officer | 2026-05-01 | J | 203 | — |
| Lenkowsky Adam | EVP, Chief Commercial Officer | 2026-05-01 | Tax withheld | 599 | $58.22 |
| Shanahan Karin | EVP, Chief Supply Chain & Ops | 2026-04-01 | Option exercise | 3,307 | — |
| Shanahan Karin | EVP, Chief Supply Chain & Ops | 2026-04-01 | Tax withheld | 1,692 | $61.73 |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000014272 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.